Food Additive Emulsifier Intake Linked to Risk for CVD
Higher intake of celluloses (E460 to E468) positively associated with higher risks for CVD and coronary heart disease
Upfront Combo Lipid-Lowering Therapy Best for Acute Coronary Syndrome
Combination approach better than statin monotherapy for all-cause mortality at one, three, and five years in acute coronary syndromes
Pulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019
Age-adjusted mortality rate increased for men versus women and Black versus White patients
Statin Use Linked to Reduced Risk for CRC Incidence, Mortality in Patients With IBD
Benefit for incident CRC was duration-dependent, with significantly reduced risk after two or more years of use
DOACs Reduce Dementia Risk Versus Warfarin in A-Fib
Significant reductions were seen in dementia risk for rivaroxaban, apixaban, and dabigatran versus warfarin in network meta-analysis
Availability of CVD Meds Varies by Low-Cost Generic Program
Variation in coverage seen by program, drug, and cardiovascular disease condition
Obesity-Linked CV Mortality Increased From 1999 to 2020
Highest age-adjusted mortality rates seen for Black individuals, and greatest temporal increase found in American Indian and Alaska Native individuals
Major Discharge Barriers Present for One in 10 Hospitalized Patients
Prolonged length of stay is often due to need for skilled therapy or daily living support in medically ready patients
Psychosocial Stressors Tied to Incident Atrial Fibrillation in Postmenopausal Women
Analysis revealed two clusters of highly correlated psychosocial factors -- stress and strain
Even Five Years Postapproval, Many Drug Studies Remain Nonpublic
Authors urge greater transparency of study results for drugs approved by the FDA
